Global Human Coagulation Factor VII Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published On: August 2018
 
Report ID:294315
 
 
Pages: 119




Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

Scope of the Report:

This report focuses on the Human Coagulation Factor VII in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

In the last several years, global market of human coagulation factor VII developed Fluctuating ly, with an average growth rate of 0.03%. In 2016, global capacity of Human Coagulation Factor VII is nearly 2309 K MG.

North America is the largest consumption market of Human Coagulation Factor VII, with sales market share 45.13%. The second place is Europe, following North America with the sales market share of 22%.And the Europe production market share of Human Coagulation Factor VII is 100%.

Asia (EX. China) is another important market of Human Coagulation Factor VII, enjoying 9.66% sales market share. And in China, the market share is 2.38%.

The worldwide market for Human Coagulation Factor VII is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

NovoNordisk

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Type I

Type II

Market Segment by Applications, can be divided into

Hemophilia Treatment

Surgery

Other

There are 15 Chapters to deeply display the global Human Coagulation Factor VII market.

Chapter 1, to describe Human Coagulation Factor VII Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Coagulation Factor VII, with sales, revenue, and price of Human Coagulation Factor VII, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Coagulation Factor VII, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Human Coagulation Factor VII market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Human Coagulation Factor VII sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Human Coagulation Factor VII Introduction

1.2 Market Analysis by Type

1.2.1 Type I

1.2.2 Type II

1.3 Market Analysis by Applications

1.3.1 Hemophilia Treatment

1.3.2 Surgery

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 NovoNordisk

2.1.1 Business Overview

2.1.2 Human Coagulation Factor VII Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 NovoNordisk Human Coagulation Factor VII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Human Coagulation Factor VII Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Human Coagulation Factor VII Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Human Coagulation Factor VII Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Human Coagulation Factor VII Manufacturer Market Share in 2017

3.3.2 Top 6 Human Coagulation Factor VII Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Human Coagulation Factor VII Market Analysis by Regions

4.1 Global Human Coagulation Factor VII Sales, Revenue and Market Share by Regions

4.1.1 Global Human Coagulation Factor VII Sales and Market Share by Regions (2013-2018)

4.1.2 Global Human Coagulation Factor VII Revenue and Market Share by Regions (2013-2018)

4.2 North America Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

4.3 Europe Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

4.5 South America Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

5 North America Human Coagulation Factor VII by Countries

5.1 North America Human Coagulation Factor VII Sales, Revenue and Market Share by Countries

5.1.1 North America Human Coagulation Factor VII Sales and Market Share by Countries (2013-2018)

5.1.2 North America Human Coagulation Factor VII Revenue and Market Share by Countries (2013-2018)

5.2 United States Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

5.3 Canada Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

5.4 Mexico Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

6 Europe Human Coagulation Factor VII by Countries

6.1 Europe Human Coagulation Factor VII Sales, Revenue and Market Share by Countries

6.1.1 Europe Human Coagulation Factor VII Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Human Coagulation Factor VII Revenue and Market Share by Countries (2013-2018)

6.2 Germany Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

6.3 UK Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

6.4 France Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

6.5 Russia Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

6.6 Italy Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

7 Asia-Pacific Human Coagulation Factor VII by Countries

7.1 Asia-Pacific Human Coagulation Factor VII Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Human Coagulation Factor VII Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Human Coagulation Factor VII Revenue and Market Share by Countries (2013-2018)

7.2 China Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

7.3 Japan Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

7.4 Korea Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

7.5 India Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

8 South America Human Coagulation Factor VII by Countries

8.1 South America Human Coagulation Factor VII Sales, Revenue and Market Share by Countries

8.1.1 South America Human Coagulation Factor VII Sales and Market Share by Countries (2013-2018)

8.1.2 South America Human Coagulation Factor VII Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

8.3 Argentina Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

8.4 Colombia Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

9 Middle East and Africa Human Coagulation Factor VII by Countries

9.1 Middle East and Africa Human Coagulation Factor VII Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Human Coagulation Factor VII Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Human Coagulation Factor VII Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

9.3 UAE Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

9.4 Egypt Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

9.5 Nigeria Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

9.6 South Africa Human Coagulation Factor VII Sales and Growth Rate (2013-2018)

10 Global Human Coagulation Factor VII Market Segment by Type

10.1 Global Human Coagulation Factor VII Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Human Coagulation Factor VII Sales and Market Share by Type (2013-2018)

10.1.2 Global Human Coagulation Factor VII Revenue and Market Share by Type (2013-2018)

10.2 Type I Sales Growth and Price

10.2.1 Global Type I Sales Growth (2013-2018)

10.2.2 Global Type I Price (2013-2018)

10.3 Type II Sales Growth and Price

10.3.1 Global Type II Sales Growth (2013-2018)

10.3.2 Global Type II Price (2013-2018)

11 Global Human Coagulation Factor VII Market Segment by Application

11.1 Global Human Coagulation Factor VII Sales Market Share by Application (2013-2018)

11.2 Hemophilia Treatment Sales Growth (2013-2018)

11.3 Surgery Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 Human Coagulation Factor VII Market Forecast (2018-2023)

12.1 Global Human Coagulation Factor VII Sales, Revenue and Growth Rate (2018-2023)

12.2 Human Coagulation Factor VII Market Forecast by Regions (2018-2023)

12.2.1 North America Human Coagulation Factor VII Market Forecast (2018-2023)

12.2.2 Europe Human Coagulation Factor VII Market Forecast (2018-2023)

12.2.3 Asia-Pacific Human Coagulation Factor VII Market Forecast (2018-2023)

12.2.4 South America Human Coagulation Factor VII Market Forecast (2018-2023)

12.2.5 Middle East and Africa Human Coagulation Factor VII Market Forecast (2018-2023)

12.3 Human Coagulation Factor VII Market Forecast by Type (2018-2023)

12.3.1 Global Human Coagulation Factor VII Sales Forecast by Type (2018-2023)

12.3.2 Global Human Coagulation Factor VII Market Share Forecast by Type (2018-2023)

12.4 Human Coagulation Factor VII Market Forecast by Application (2018-2023)

12.4.1 Global Human Coagulation Factor VII Sales Forecast by Application (2018-2023)

12.4.2 Global Human Coagulation Factor VII Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2020 Fior Market Research LLP, All Rights Reserved.